Want to see TSE:VIBE full AI Analyst Report?
Vibe Bioscience Ltd (VIBE) Ratios
Vibe Bioscience Ltd Ratios
TSE:VIBE's free cash flow for Q2 2026 was $14.76K. For the 2026 fiscal year, TSE:VIBE's free cash flow was increased by $0.00 and operating cash flow was $14.76K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.19 | 0.21 | 0.37 | 0.77 | 1.51 |
| Quick Ratio | 0.15 | 0.13 | 0.13 | 0.50 | 1.14 |
| Cash Ratio | 0.05 | 0.07 | 0.09 | 0.45 | 1.07 |
| Solvency Ratio | -0.08 | -0.33 | -0.63 | -0.61 | -0.27 |
| Operating Cash Flow Ratio | 0.00 | 0.02 | -0.22 | -0.19 | 0.10 |
| Short-Term Operating Cash Flow Coverage | 1.03 | 4.01 | -37.34 | -20.54 | 4.45 |
| Net Current Asset Value | $ -15.36M | $ -13.56M | $ -10.66M | $ -5.85M | $ 1.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.23 | 0.18 | 0.13 | 0.09 |
| Debt-to-Equity Ratio | -0.32 | -0.49 | 2.68 | 0.28 | 0.13 |
| Debt-to-Capital Ratio | -0.48 | -0.97 | 0.73 | 0.22 | 0.12 |
| Long-Term Debt-to-Capital Ratio | -0.12 | -0.20 | 0.46 | 0.08 | 0.06 |
| Financial Leverage Ratio | -1.44 | -2.16 | 15.09 | 2.11 | 1.54 |
| Debt Service Coverage Ratio | -2.90 | -23.20 | -31.98 | -17.02 | -7.35 |
| Interest Coverage Ratio | 3.15 | -15.16 | -22.88 | -25.63 | 3.42 |
| Debt to Market Cap | 21.82 | 27.17 | 0.51 | 0.01 | 0.49 |
| Interest Debt Per Share | 2.41 | 2.54 | 0.03 | 0.03 | 0.03 |
| Net Debt to EBITDA | 1.19 | -0.39 | -0.20 | 0.32 | 5.65 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.66% | 37.26% | 36.56% | 31.36% | 28.75% |
| EBIT Margin | 2.63% | -38.97% | -70.28% | -23.26% | -7.87% |
| EBITDA Margin | 8.17% | -30.73% | -59.50% | -17.52% | -3.79% |
| Operating Profit Margin | 2.63% | -20.39% | -35.74% | -23.26% | 2.38% |
| Pretax Profit Margin | -2.37% | -40.32% | -71.84% | -39.85% | -8.57% |
| Net Profit Margin | -13.99% | -51.43% | -78.68% | -45.64% | -14.68% |
| Continuous Operations Profit Margin | -13.99% | -51.43% | -78.68% | -45.64% | -14.68% |
| Net Income Per EBT | 589.50% | 127.57% | 109.51% | 114.53% | 171.29% |
| EBT Per EBIT | -90.11% | 197.77% | 200.99% | 171.31% | -360.27% |
| Return on Assets (ROA) | -22.40% | -57.90% | -68.38% | -36.50% | -13.07% |
| Return on Equity (ROE) | 32.17% | 125.32% | -1031.93% | -77.08% | -20.09% |
| Return on Capital Employed (ROCE) | -8.25% | 86.19% | -130.25% | -30.55% | 2.86% |
| Return on Invested Capital (ROIC) | -9.38% | 111.53% | -114.59% | -29.62% | 2.79% |
| Return on Tangible Assets | -24.75% | -65.77% | -76.93% | -41.44% | -16.52% |
| Earnings Yield | -6240.11% | -19367.90% | -567.79% | -9.52% | -146.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.59 | 23.71 | 130.48 | 146.43 | 216.21 |
| Payables Turnover | 2.13 | 1.67 | 1.98 | 4.11 | 7.16 |
| Inventory Turnover | 14.35 | 7.29 | 3.05 | 5.25 | 6.60 |
| Fixed Asset Turnover | 2.90 | 1.82 | 1.42 | 1.38 | 2.23 |
| Asset Turnover | 1.60 | 1.13 | 0.87 | 0.80 | 0.89 |
| Working Capital Turnover Ratio | -1.42 | -1.32 | -2.77 | 20.67 | 11.23 |
| Cash Conversion Cycle | -117.03 | -152.53 | -62.21 | -16.78 | 6.01 |
| Days of Sales Outstanding | 28.98 | 15.39 | 2.80 | 2.49 | 1.69 |
| Days of Inventory Outstanding | 25.43 | 50.06 | 119.78 | 69.48 | 55.31 |
| Days of Payables Outstanding | 171.44 | 217.98 | 184.79 | 88.75 | 50.98 |
| Operating Cycle | 54.41 | 65.45 | 122.58 | 71.97 | 57.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.06 | 0.22 | -0.03 | -0.02 | 0.01 |
| Free Cash Flow Per Share | 0.02 | 0.19 | -0.03 | -0.03 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | 1.37 | 7.56 | -37.69 | -1.13 | 0.11 |
| Capital Expenditure Coverage Ratio | 1.37 | 7.56 | -37.69 | -1.13 | 0.11 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.09 | -0.94 | -0.58 | 0.30 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.02 | -0.19 | -0.09 | 0.03 |
| Free Cash Flow Yield | 43.70% | 600.73% | -141.70% | -3.74% | -245.14% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.02 | -0.01 | -0.18 | -10.50 | -0.68 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.14 | 4.79 | 0.10 |
| Price-to-Book (P/B) Ratio | -0.01 | -0.01 | 1.82 | 8.10 | 0.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.29 | 0.17 | -0.71 | -26.74 | -0.41 |
| Price-to-Operating Cash Flow Ratio | 0.62 | 0.14 | -0.72 | -50.48 | 3.46 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | -0.01 | -0.11 | 0.00 |
| Enterprise Value Multiple | 1.22 | -0.40 | -0.44 | -27.04 | 3.00 |
| Enterprise Value | 1.75M | 1.55M | 3.68M | 98.11M | -3.33M |
| EV to EBITDA | 1.22 | -0.40 | -0.44 | -27.04 | 3.00 |
| EV to Sales | 0.10 | 0.12 | 0.26 | 4.74 | -0.11 |
| EV to Free Cash Flow | 101.66 | 7.63 | -1.32 | -26.43 | 0.46 |
| EV to Operating Cash Flow | 27.46 | 6.62 | -1.36 | -49.89 | -3.92 |
| Tangible Book Value Per Share | -8.02 | -6.08 | -0.01 | 0.08 | 0.15 |
| Shareholders’ Equity Per Share | -7.06 | -4.83 | 0.01 | 0.11 | 0.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -4.89 | -0.28 | -0.10 | -0.15 | -0.71 |
| Revenue Per Share | 16.24 | 11.78 | 0.14 | 0.18 | 0.30 |
| Net Income Per Share | -2.27 | -6.06 | -0.11 | -0.08 | -0.04 |
| Tax Burden | 5.89 | 1.28 | 1.10 | 1.15 | 1.71 |
| Interest Burden | -0.90 | 1.03 | 1.02 | 1.71 | 1.09 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.36 | 0.49 | 0.59 | 0.42 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 |
| Income Quality | -0.03 | -0.04 | 0.24 | 0.21 | -0.20 |
Currency in USD
